Axsome Therapeutics, Inc.
SEC 4 · Filed
0001193125-26-045110Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Feb 10, 2026
Exercise or conversion by Coleman Mark
- Security
- Stock Option (Right to Buy)
- Shares
-
5,193
- Price per share
-
0.00
Structured facts
{
"code": "M",
"date": "2026-02-10",
"direction": "D",
"exercise_price": "8.02",
"expiration": "2026-05-27",
"footnotes": {
"F1": "Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."
},
"owners": [
{
"cik": "0001658379",
"name": "Coleman Mark",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "0",
"price": "0",
"row": 1,
"rule_10b5_1": "false",
"security": "Stock Option (Right to Buy)",
"shares": "5193",
"table": "II",
"underlying_security": "Common Stock",
"underlying_shares": "5193"
}Insider transactionsEvent date Feb 10, 2026
Exercise or conversion by Coleman Mark
- Security
- Common Stock
- Shares
-
5,193
- Price per share
-
8.02
Structured facts
{
"code": "M",
"date": "2026-02-10",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."
},
"owners": [
{
"cik": "0001658379",
"name": "Coleman Mark",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "53405",
"price": "8.02",
"row": 1,
"rule_10b5_1": "false",
"security": "Common Stock",
"shares": "5193",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}